Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX14
Healthy Male Volunteers
Phase I

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects

HLX10 + chemotherapy
Cervical Cancer
phase II

A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy

HLX10+Chemotherapy
Extensive Stage Small Cell Lung Cancer
Phase III
A Randomized, Double-blind, Placebo?Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
HLX10+chemotherapy
Squamous Non Small Cell Lung Cancer
Phase III
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
HLX10+Chemotherapy
Esophageal Squamous Cell Carcinoma
Phase III
A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
两性色午夜视在线观看